U.S. federal trademark · Serial No. 87682083 · Reg. No. 5497375
Pharmaceutical and medicinal preparations for the treatment of cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, bacterial infection, peripheral blood stem cell mobilization, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.